Per the Pharmasset call yesterday (didn't catch all of it yet) they indicated that Roche confirmed will have some data from the low/high high/low cohort as well as the "high/high" 200mg q8 191 and 1000mg 7128. http://investor.pharmasset.com/events.cfm